Journal rejects article after objections from marketing department

A leading nephrology journal has rejected a guest editorial questioning the efficacy of epoetin in end stage renal disease, despite favourable peer reviews, apparently because it feared losing advertising. In a letter to the author of the proposed editorial, the executive editor of the California based journal Transplantation and Dialysis said he had been “overruled by our marketing department.”

The editorial was written by Dennis Cotter, president of the non-profit making Medical Technology and Practice Patterns Institute. In it, he argued that the US National Kidney Foundation's existing guidelines on end stage renal disease …